BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26072209)

  • 1. Possibilities and limitations of signal summing for an immunosuppressant LC-MS/MS method.
    Pauwels S; Jans I; Peersman N; Billen J; Vanderschueren D; Desmet K; Vermeersch P
    Anal Bioanal Chem; 2015 Aug; 407(20):6191-9. PubMed ID: 26072209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
    Heideloff C; Payto D; Wang S
    Ther Drug Monit; 2013 Apr; 35(2):246-50. PubMed ID: 23503452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
    Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
    Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
    Verstraete AG; Rigo-Bonnin R; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
    Ther Drug Monit; 2018 Feb; 40(1):59-68. PubMed ID: 29210975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
    Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
    Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-throughput LC-MS/MS method for the quantification of four immunosu- ppressants drugs in whole blood.
    Gong ZS; Wu ZH; Xu SX; Han WN; Jiang XM; Liu HP; Yan-Li ; Wei-Hu ; Yan-Wang
    Clin Chim Acta; 2019 Nov; 498():21-26. PubMed ID: 31351928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
    McMillin GA; Johnson-Davis K; Dasgupta A
    Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a small particle solid-core packing for improved efficiency and rapid measurement of sirolimus and everolimus by LC-MS/MS.
    Morgan P; Nwafor M; Tredger M
    Biomed Chromatogr; 2016 Jun; 30(6):983-5. PubMed ID: 26419504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.
    Ivanova M; Artusi C; Polo G; Zaninotto M; Plebani M
    Clin Chem Lab Med; 2011 Jul; 49(7):1151-8. PubMed ID: 21574883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid determination of immunosuppressive drug concentrations in whole blood by coated blade spray-tandem mass spectrometry (CBS-MS/MS).
    Gómez-Ríos GA; Tascon M; Reyes-Garcés N; Boyacı E; Poole JJ; Pawliszyn J
    Anal Chim Acta; 2018 Jan; 999():69-75. PubMed ID: 29254576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.
    Morgan PE; Brown NW; Tredger JM
    Ther Drug Monit; 2014 Jun; 36(3):358-65. PubMed ID: 24305629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
    Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
    Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
    Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
    Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.
    Mueller DM; Rentsch KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):1007-12. PubMed ID: 20308022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.
    Koster RA; Veenhof H; Botma R; Hoekstra AT; Berger SP; Bakker SJ; Alffenaar JC; Touw DJ
    Bioanalysis; 2017 Apr; 9(7):553-563. PubMed ID: 28300419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.
    Pohanka A; Rosenborg S; Lindh JD; Beck O
    Clin Biochem; 2016 Sep; 49(13-14):1024-31. PubMed ID: 27372284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.